National Psoriasis Foundation: “CBD for Psoriasis and PsA.”
FDA: “What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD,” “FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns,” “FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief.”
Karger Journals: “Efficacy and Tolerability of a Shampoo Containing Broad-Spectrum Cannabidiol in the Treatment of Scalp Inflammation in Patients with Mild to Moderate Scalp Psoriasis or Seborrheic Dermatitis.”
La Clinica Therapeutica: “Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.”
JAMA: “Labeling Accuracy of Cannabidiol Extracts Sold Online.”
Cedars Sinai: “CBD: What You Need to Know Before You Try.”
Adam Friedman, MD, professor and chair of dermatology, George Washington School of Medicine and Health Sciences.
Joel Gelfand, MD, professor of dermatology and of epidemiology; vice chair of clinical research and medical director, Dermatology Clinical Studies Unit; director, Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine.
James Ralston, MD, Dermatology Center of McKinney, McKinney, TX.
Jim Snedden, 55, Goshen, NY.
Cynthia Covert, 52, Moreno Valley, CA.
View original article here Source